DEVELOPMENT OF NOVEL INHIBITORS OF GPCR-MEDIATED PIK3CB ACTIVATION

$125,250FY2014Department of DefenseDOD

Albert Einstein College Of Medicine, Bronx NY

Investigators

View source on USAspending →